Oppenheimer & Co. Inc. Reduces Position in Mettler-Toledo International Inc. (NYSE:MTD)

Oppenheimer & Co. Inc. decreased its position in Mettler-Toledo International Inc. (NYSE:MTD) by 7.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 246 shares of the medical instruments supplier’s stock after selling 20 shares during the period. Oppenheimer & Co. Inc.’s holdings in Mettler-Toledo International were worth $369,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Orion Portfolio Solutions LLC boosted its position in Mettler-Toledo International by 3.0% in the first quarter. Orion Portfolio Solutions LLC now owns 696 shares of the medical instruments supplier’s stock valued at $927,000 after buying an additional 20 shares during the last quarter. Advisors Asset Management Inc. boosted its holdings in shares of Mettler-Toledo International by 17.1% in the 1st quarter. Advisors Asset Management Inc. now owns 1,366 shares of the medical instruments supplier’s stock valued at $1,819,000 after acquiring an additional 199 shares during the last quarter. Toronto Dominion Bank raised its holdings in shares of Mettler-Toledo International by 47.9% during the first quarter. Toronto Dominion Bank now owns 12,772 shares of the medical instruments supplier’s stock worth $17,003,000 after purchasing an additional 4,135 shares during the last quarter. Capital Research Global Investors raised its holdings in shares of Mettler-Toledo International by 40.0% during the first quarter. Capital Research Global Investors now owns 14,199 shares of the medical instruments supplier’s stock worth $18,903,000 after purchasing an additional 4,058 shares during the last quarter. Finally, Epoch Investment Partners Inc. lifted its position in Mettler-Toledo International by 40.9% during the first quarter. Epoch Investment Partners Inc. now owns 81,234 shares of the medical instruments supplier’s stock valued at $108,146,000 after purchasing an additional 23,593 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Buying and Selling

In related news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares in the company, valued at approximately $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,195.00 on Friday. Mettler-Toledo International Inc. has a 1-year low of $1,059.08 and a 1-year high of $1,546.93. The company has a market cap of $25.21 billion, a price-to-earnings ratio of 32.22, a PEG ratio of 3.83 and a beta of 1.16. The stock has a 50 day simple moving average of $1,365.15 and a 200-day simple moving average of $1,398.13.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. Analysts anticipate that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current fiscal year.

Analyst Ratings Changes

MTD has been the topic of several analyst reports. Stifel Nicolaus reduced their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. Robert W. Baird reduced their price target on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research report on Monday, November 11th. Evercore ISI boosted their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. raised their price objective on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a research note on Monday, August 5th. Finally, Wells Fargo & Company cut their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a report on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $1,338.75.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.